| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/29/2010 | US20100105616 Polyethylene glycol-g-csf conjugate |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100104624 Combination therapy using phosphodiesterase inhibitors |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104544 Selective cell therapy for the treatment of renal failure |
| 04/29/2010 | US20100104543 Cellular compositions and methods of making and using them |
| 04/29/2010 | US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 04/29/2010 | US20100104530 Anti-vpac1 antibodies and their uses |
| 04/28/2010 | EP2180049A1 Devices and compositions for lysis of occlusive blood clots while sparing wound sealing clots comprising a mutant pro-urokinase |
| 04/28/2010 | EP2179987A2 Anti-sickling agents |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 04/28/2010 | EP2178849A1 Integrated photoactive agents and uses thereof |
| 04/28/2010 | EP2178839A2 New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution |
| 04/28/2010 | EP2178838A2 New thrombin function compounds and pharmaceutical compositions based on them |
| 04/28/2010 | EP2178818A2 Treatments using vitamin k analogues and derivatives |
| 04/28/2010 | EP2178556A2 Protein c for use in maintaining hemostasis |
| 04/28/2010 | EP1474142B1 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof |
| 04/28/2010 | EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | CN1954818B Application of phillyrin in preparation for treating endotoxemia |
| 04/28/2010 | CN1880458B Human source chromosome targeting vector of human beta-globin gene cluster and application therefor |
| 04/28/2010 | CN1668290B Modified amino acid for the inhibition of platelet aggregation |
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN1456257B Fresh motherwort particle preparing method |
| 04/28/2010 | CN101698078A Traditional Chinese medicine for treating septicemia |
| 04/28/2010 | CN101698070A Traditional Chinese medicine for treating anaemia |
| 04/28/2010 | CN101698037A Medicine for treating uterine bleeding and preparation process thereof |
| 04/28/2010 | CN101698019A Traditional Chinese medicine for treating chronic anaemia |
| 04/28/2010 | CN101697988A Taste hiding composition and application thereof in Xuesaitong chewable tablet |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |
| 04/27/2010 | US7705119 A Deltorphin-E polypeptide having a specific amino acid sequence and acarrier; antishock agents; opiod receptor agonists; nucleotide sequence;hypertensive agents; antiinflammatory agents; antiischemic agents; surgery;restoring perfusion to organs and tissues; prophylaxis |
| 04/27/2010 | US7705043 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases |
| 04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | CA2427482C Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 04/27/2010 | CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/24/2010 | CA2689482A1 Active agents, compositions, and methods for inhibiting and reversing platelet function |
| 04/22/2010 | WO2010045568A1 Modified blood factors comprising a low degree of water soluble polymer |
| 04/22/2010 | WO2010045518A1 Compositions containing thrombomodulin domains and uses thereof |
| 04/22/2010 | WO2010045306A2 Azine derivatives and methods of use thereof |
| 04/22/2010 | WO2010045166A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/22/2010 | WO2010043076A1 A method for constructing human placental mesenchymal cells library which is suitable for clinical application |
| 04/22/2010 | WO2010022380A3 Linear polyol stabilized polyfluoroacrylate compositions |
| 04/22/2010 | WO2009158309A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 04/22/2010 | WO2009130602A9 Factor ix conjugates with extended half-lives |
| 04/22/2010 | US20100099721 Novel compounds for the treatment of neurological disorders |
| 04/22/2010 | US20100099706 Argatroban formulation |
| 04/22/2010 | US20100099705 Argatroban formulation |
| 04/22/2010 | US20100099647 Aqueous Iron Carbohydrate Complexes, Their Production And Medicaments Containing Them |
| 04/22/2010 | US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 04/22/2010 | US20100098666 Humanized Viral Vectors and Methods of Use Thereof |
| 04/22/2010 | US20100098658 Biopolymer Conjugates Comprising an Interleukin-11 Analog |
| 04/22/2010 | CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/22/2010 | CA2739491A1 Azine derivatives and methods of use thereof |
| 04/22/2010 | CA2738679A1 Modified blood factors comprising a low degree of water soluble polymer |
| 04/21/2010 | EP2177530A1 Octapeptide having antiangiogenic activity |
| 04/21/2010 | EP2177517A1 Amino substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimide for reducing TNF alpha levels |
| 04/21/2010 | EP2177513A1 Phenylacetic acid compound |
| 04/21/2010 | EP2177225A1 Peritoneal dialysate |
| 04/21/2010 | EP2177212A1 Methods of using lamellar bodies for therapeutic purposes |
| 04/21/2010 | EP2176264A1 Imidazo-, pyrazolopyrazines and imidazotriazines and their use |
| 04/21/2010 | EP2176258A1 Piperidine derivatives useful as orexin receptor antagonists |
| 04/21/2010 | EP2176223A1 Malonamide derivatives with antithrombotic activity |
| 04/21/2010 | EP2175872A2 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | EP1258252B1 Integrin expression inhibitors |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | CN1978462B Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking |
| 04/21/2010 | CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition |
| 04/21/2010 | CN101695537A Hematogenesis recovery oral liquid and preparation method thereof |
| 04/21/2010 | CN101695528A Medicament for purifying blood |
| 04/21/2010 | CN101695523A Lactation qi and blood tonifying medicament and preparation method thereof |
| 04/21/2010 | CN101695496A Medicinal composition containing triflusal and clopidogrel |
| 04/21/2010 | CN101695485A Use of chlorogenic acid in preparing medicament for treating thrombocytopenia and anemia |
| 04/21/2010 | CN101695475A Ozagrel sodium injection and preparation method thereof |
| 04/21/2010 | CN101240026B Conjugate constructed from normal tridecyl and RGD peptide, and its synthesis and application in medicine |
| 04/21/2010 | CN101172161B Water-soluble polymers decorated G-CSF conjugates |
| 04/21/2010 | CN101167719B Gallo catechin and gallate microcapsule granule and preparation technique thereof |
| 04/21/2010 | CN101112481B Medicine for treating functional uterine bleeding and method for preparing the same |
| 04/20/2010 | US7700778 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/20/2010 | US7700733 Factor VII or VIIa polypeptide variants |
| 04/20/2010 | US7700608 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700554 Compositions for modulating blood-brain barrier transport |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | US7700077 comprising from 1300 to 1500 mg/l of Na+, from 4500 to 6500 mg/l of K+, from 50 to 1300 mg/l of Mg++, from 20 to 350 mg/l of ca++, from 4000 to 6000 mg/l of Cl-, a pH of from 4-9, and an osmolality of from 150-700 mOsm/kg; for treating and cleaning the eye |
| 04/20/2010 | CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 04/20/2010 | CA2432178C Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
| 04/20/2010 | CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 04/20/2010 | CA2361587C Methods and compositions to enhance white blood cell count |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/15/2010 | WO2010042626A1 1-phenylpyrrole compounds |
| 04/15/2010 | WO2010042475A1 Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 04/15/2010 | WO2010041726A1 Substituted tricyclic heteroaryl compound |
| 04/15/2010 | WO2010041636A1 Tissue plug |
| 04/15/2010 | WO2010041263A1 Increasing low platelets instantly |
| 04/15/2010 | WO2010040789A1 Iron source product in the form of capsules and process for their preparation |